Literature DB >> 24817451

Surveillance of arteriovenous accesses with the use of duplex Doppler ultrasonography.

Jan Malik1, Jaroslav Kudlicka, Ludmila Novakova, Josef Adamec, Hana Malikova, Jan Kavan.   

Abstract

Stenosis is the most frequent vascular access complication and is responsible for access thrombosis and thus long-term patency limitation. Regular arteriovenous graft (AVG) examination by ultrasonography and preemptive balloon angioplasty prolong AVG cumulative patency according to some, but by far not all trials. This was why the routine use of ultrasound surveillance is not recommended recently.In this review we show huge differences in the definition of stenosis significance among the trials and other probable factors, which may have caused the contradiction of the results. Without precise definition of stenosis significance, many AVGs have been undergoing unnecessary balloon interventions with high morbidity, high cost and low benefit.

Entities:  

Mesh:

Year:  2014        PMID: 24817451     DOI: 10.5301/jva.5000240

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  3 in total

1.  Patency Outcomes of Arteriovenous Fistulas and Grafts for Hemodialysis Access: A Trade-Off between Nonmaturation and Long-Term Complications.

Authors:  Bram M Voorzaat; Cynthia J Janmaat; Koen E A van der Bogt; Friedo W Dekker; Joris I Rotmans
Journal:  Kidney360       Date:  2020-07-23

2.  Mean Platelet Volume Predicts Vascular Access Events in Hemodialysis Patients.

Authors:  Guillaume Lano; Marion Sallée; Marion Pelletier; Stanislas Bataille; Megan Fraisse; Yaël Berda-Haddad; Philippe Brunet; Stéphane Burtey
Journal:  J Clin Med       Date:  2019-05-04       Impact factor: 4.241

Review 3.  Arteriovenous Hemodialysis Access Stenosis Diagnosed by Duplex Doppler Ultrasonography: A Review.

Authors:  Jan Malik; Cora de Bont; Anna Valerianova; Zdislava Krupickova; Ludmila Novakova
Journal:  Diagnostics (Basel)       Date:  2022-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.